Picture of Senseonics Holdings logo

SENS Senseonics Holdings Share Price

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapSucker Stock

Momentum

Relative Strength (%)
1m-26.18%
3m-25.18%
6m-33.55%
1yr-47.45%
Volume Change (%)
10d/3m+6.67%
Price vs... (%)
52w High-61.98%
50d MA-29.84%
200d MA-33.68%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-62.5%
Return on Equity-363.59%
Operating Margin-337.66%

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202431st Dec 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of Senseonics Holdings EPS forecast chart

Profile Summary

Senseonics Holdings, Inc. is a medical technology company focused on the development and manufacturing of glucose monitoring products designed to transform lives in the diabetes community. Its glucose monitoring (CGM) systems, Eversense, Eversense XL, and Eversense E3 include a small sensor inserted completely under the skin that communicates with a smart transmitter worn over the sensor. The glucose data are automatically sent every five minutes to a mobile app on the user's smartphone. Eversense consists of three primary components: a small sensor inserted subcutaneously under the skin by a healthcare provider; an external removable smart transmitter that receives, assesses and relays data from the sensor and provides vibratory alerts; and a mobile app that receives data from the transmitter and provides real-time glucose readings, alerts and other data the person's mobile device. Its CGM system continually and accurately measures a person's glucose levels for up to six months.

Directors

Last Annual
December 31st, 2023
Last Interim
December 31st, 2023
Incorporated
December 4th, 2015
Public Since
March 4th, 2015
No. of Shareholders
168
No. of Employees
132
Sector
Healthcare Equipment & Supplies
Industry
Healthcare
Exchange
us flag iconNYSE MKT
Shares in Issue
530,817,549

SENS Share Price Performance

Upcoming Events for SENS

Q1 2024 Senseonics Holdings Inc Earnings Release

Senseonics Holdings Inc Annual Shareholders Meeting

Senseonics Holdings Inc Annual Shareholders Meeting

Q2 2024 Senseonics Holdings Inc Earnings Release

Similar to SENS

FAQ